Imperial College London

ProfessorMichaelPolkey

Faculty of MedicineNational Heart & Lung Institute

Professor of Respiratory Medicine
 
 
 
//

Contact

 

+44 (0)20 7351 8029m.polkey

 
 
//

Location

 

Respiratory MuscRoyal BromptonRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Abdulai:2017:10.1164/rccm.201703-0615CI,
author = {Abdulai, RM and Jellesmark, Jensen T and Patel, NR and Polkey, MI and Jansson, P and Celli, BR and Rennard, SI},
doi = {10.1164/rccm.201703-0615CI},
journal = {American Journal of Respiratory and Critical Care Medicine},
pages = {433--449},
title = {Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease},
url = {http://dx.doi.org/10.1164/rccm.201703-0615CI},
volume = {197},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Important features of both stable and acute exacerbation of COPD are skeletal muscle weakness and wasting. Limb muscle dysfunction during an exacerbation has been linked to various adverse outcomes, including prolonged hospitalization, readmission, and mortality. The contributing factors leading to muscle dysfunction are similar to those seen in stable COPD: disuse, nutrition/energy balance, hypercapnia, hypoxemia, electrolyte derangements, inflammation, and drugs (i.e., glucocorticoids). These factors may be the trigger for a downstream cascade of local inflammatory changes, pathway process alterations, and structural degradation. Ultimately, the clinical effects can be wide ranging and include reduced limb muscle strength. Current therapies, such as pulmonary/physical rehabilitation have limited impact due to low participation rates. Recently, novel drugs have been developed in similar disorders and learnings from these studies can be used as a foundation to facilitate discovery in patients hospitalized with a COPD exacerbation. Nevertheless, investigators should approach this patient population with knowledge of the limitations of each intervention. In this concise clinical review, we provide an overview of acute muscle dysfunction in patients hospitalized with acute exacerbation of COPD (AECOPD) and a strategic approach to drug development in this setting.
AU - Abdulai,RM
AU - Jellesmark,Jensen T
AU - Patel,NR
AU - Polkey,MI
AU - Jansson,P
AU - Celli,BR
AU - Rennard,SI
DO - 10.1164/rccm.201703-0615CI
EP - 449
PY - 2017///
SN - 1073-449X
SP - 433
TI - Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease
T2 - American Journal of Respiratory and Critical Care Medicine
UR - http://dx.doi.org/10.1164/rccm.201703-0615CI
UR - https://www.ncbi.nlm.nih.gov/pubmed/29064260
UR - http://hdl.handle.net/10044/1/54668
VL - 197
ER -